| Lauren Rhae Draper, MD | |
|
1465 S Grand Blvd, Department Of Pediatrics Division Of Heme/onc, St. Louis, MO 63104 | |
| (314) 577-5638 | |
| (314) 268-4081 |
| Full Name | Lauren Rhae Draper |
|---|---|
| Gender | Female |
| Speciality | Pediatrics - Pediatric Hematology-oncology |
| Location | 1465 S Grand Blvd, St. Louis, Missouri |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043500416 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2080P0207X | Pediatrics - Pediatric Hematology-oncology | 2018010234 (Missouri) | Primary |
| Entity Name | Ssm Health Care St Louis |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275586174 PECOS PAC ID: 7810800737 Enrollment ID: O20031118000393 |
News Archive
Osseon Therapeutics, Inc., a biomedical device company based in Santa Rosa, California, today received a notice of allowance for its spinal vertebral compression fracture (VCF) technology. The company which was started in 2006 has thirteen additional patent applications pending in the United States and throughout the world for related spinal therapies and devices. The lead inventor for this inaugural patent is Dr. Y. King Liu, one of three founders of Osseon.
Sirolimus, whether given at the time of liver transplantation or after, is associated with poorer outcomes in patients with hepatitis C virus infection compared with those who do not take the immunosuppressant, shows a US study.
University of Texas Medical Branch at Galveston researchers have discovered that a form of vitamin B1 could become a new and effective treatment for one of the world's leading causes of blindness.
Researchers at Western University in London, Canada, have identified a new genetic mutation for amyotrophic lateral sclerosis (ALS), opening the door to future targeted therapies. Dr. Michael Strong, a scientist with Western's Robarts Research Institute and Distinguished University Professor in Clinical Neurological Sciences at the Schulich School of Medicine & Dentistry, and colleagues found that mutations within the ARHGEF28 gene are present in ALS.
› Verified 3 days ago
| Entity Name | Ssm Cardinal Glennon Children's Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174577670 PECOS PAC ID: 7012828163 Enrollment ID: O20031231000604 |
News Archive
Osseon Therapeutics, Inc., a biomedical device company based in Santa Rosa, California, today received a notice of allowance for its spinal vertebral compression fracture (VCF) technology. The company which was started in 2006 has thirteen additional patent applications pending in the United States and throughout the world for related spinal therapies and devices. The lead inventor for this inaugural patent is Dr. Y. King Liu, one of three founders of Osseon.
Sirolimus, whether given at the time of liver transplantation or after, is associated with poorer outcomes in patients with hepatitis C virus infection compared with those who do not take the immunosuppressant, shows a US study.
University of Texas Medical Branch at Galveston researchers have discovered that a form of vitamin B1 could become a new and effective treatment for one of the world's leading causes of blindness.
Researchers at Western University in London, Canada, have identified a new genetic mutation for amyotrophic lateral sclerosis (ALS), opening the door to future targeted therapies. Dr. Michael Strong, a scientist with Western's Robarts Research Institute and Distinguished University Professor in Clinical Neurological Sciences at the Schulich School of Medicine & Dentistry, and colleagues found that mutations within the ARHGEF28 gene are present in ALS.
› Verified 3 days ago
| Entity Name | Ssm Health Care Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306589544 PECOS PAC ID: 0143608372 Enrollment ID: O20220531002655 |
News Archive
Osseon Therapeutics, Inc., a biomedical device company based in Santa Rosa, California, today received a notice of allowance for its spinal vertebral compression fracture (VCF) technology. The company which was started in 2006 has thirteen additional patent applications pending in the United States and throughout the world for related spinal therapies and devices. The lead inventor for this inaugural patent is Dr. Y. King Liu, one of three founders of Osseon.
Sirolimus, whether given at the time of liver transplantation or after, is associated with poorer outcomes in patients with hepatitis C virus infection compared with those who do not take the immunosuppressant, shows a US study.
University of Texas Medical Branch at Galveston researchers have discovered that a form of vitamin B1 could become a new and effective treatment for one of the world's leading causes of blindness.
Researchers at Western University in London, Canada, have identified a new genetic mutation for amyotrophic lateral sclerosis (ALS), opening the door to future targeted therapies. Dr. Michael Strong, a scientist with Western's Robarts Research Institute and Distinguished University Professor in Clinical Neurological Sciences at the Schulich School of Medicine & Dentistry, and colleagues found that mutations within the ARHGEF28 gene are present in ALS.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lauren Rhae Draper, MD 1465 S Grand Blvd, Department Of Pediatrics Division Of Heme/onc, St. Louis, MO 63104 Ph: (314) 577-5638 | Lauren Rhae Draper, MD 1465 S Grand Blvd, Department Of Pediatrics Division Of Heme/onc, St. Louis, MO 63104 Ph: (314) 577-5638 |
News Archive
Osseon Therapeutics, Inc., a biomedical device company based in Santa Rosa, California, today received a notice of allowance for its spinal vertebral compression fracture (VCF) technology. The company which was started in 2006 has thirteen additional patent applications pending in the United States and throughout the world for related spinal therapies and devices. The lead inventor for this inaugural patent is Dr. Y. King Liu, one of three founders of Osseon.
Sirolimus, whether given at the time of liver transplantation or after, is associated with poorer outcomes in patients with hepatitis C virus infection compared with those who do not take the immunosuppressant, shows a US study.
University of Texas Medical Branch at Galveston researchers have discovered that a form of vitamin B1 could become a new and effective treatment for one of the world's leading causes of blindness.
Researchers at Western University in London, Canada, have identified a new genetic mutation for amyotrophic lateral sclerosis (ALS), opening the door to future targeted therapies. Dr. Michael Strong, a scientist with Western's Robarts Research Institute and Distinguished University Professor in Clinical Neurological Sciences at the Schulich School of Medicine & Dentistry, and colleagues found that mutations within the ARHGEF28 gene are present in ALS.
› Verified 3 days ago
Patrick Francis Durkin, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1 Childrens Place, 3rd Floor, Suite 3s34, St. Louis, MO 63110 Phone: 314-454-6006 | |
Donna R Halloran, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1465 S Grand Blvd, St. Louis, MO 63104 Phone: 314-268-4101 Fax: 314-577-5379 | |
Shulamit Menashe Portnoy, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1465 S Grand Blvd, St. Louis, MO 63104 Phone: 314-577-5609 Fax: 314-268-4028 | |
Felicia L. Harvey, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 11642 West Florissant, St. Louis, MO 63033 Phone: 314-838-8220 Fax: 314-838-8091 | |
Mary S Heaney, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1465 S Grand Blvd, St. Louis, MO 63104 Phone: 314-268-4101 Fax: 314-577-5379 | |
Dr. Kristen M Mennemeier, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3009 N. Ballas Rd., Suite 257c, St. Louis, MO 63131 Phone: 314-569-2112 Fax: 314-569-1270 |